Oral fluoroquinolone use is associated with an increased risk of acute kidney injury (AKI) in men, say researchers. Bird et al. examined the association in a case–control study using data from men aged 40–85 years from a US health plan claims database. Current use of oral fluoroquinolones was associated with a 2.18-fold increase in the relative risk of AKI compared with no use, but recent or past use of these drugs was not associated with AKI. Use of fluoroquinolones together with renin–angiotensin–aldosterone inhibitors was associated with an even greater increase in risk of AKI.
ORIGINAL RESEARCH PAPER
Bird, S. T. et al. Risk of acute kidney injury associated with the use of fluoroquinolones. CMAJ doi:10.1503/cmaj.121730
Rights and permissions
About this article
Cite this article
Oral fluoroquinolone use and acute kidney injury. Nat Rev Nephrol 9, 432 (2013). https://doi.org/10.1038/nrneph.2013.113
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2013.113